Drug Type Small molecule drug |
Synonyms Fasiglifam (USAN/INN) |
Target |
Mechanism GPR40 agonists(Free fatty acid receptor 1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationSpecial Review Project (CN) |
Molecular FormulaC29H32O7S |
InChIKeyBZCALJIHZVNMGJ-HSZRJFAPSA-N |
CAS Registry1000413-72-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 2 | MX | 01 Nov 2011 | |
Diabetes Mellitus, Type 2 | Phase 2 | US | 01 Nov 2011 | |
Diabetes Mellitus, Type 2 | Phase 2 | UA | 01 Nov 2011 | |
Diabetes Mellitus, Type 2 | Phase 1 | MX | 01 Nov 2011 | |
Diabetes Mellitus, Type 2 | Phase 1 | UA | 01 Nov 2011 | |
Diabetes Mellitus, Type 2 | Phase 1 | US | 01 Nov 2011 | |
Diabetes Mellitus, Type 2 | Discovery | US | 01 Nov 2011 | |
Diabetes Mellitus, Type 2 | Discovery | MX | 01 Nov 2011 | |
Diabetes Mellitus, Type 2 | Discovery | GT | 01 Nov 2011 | |
Diabetes Mellitus, Type 2 | Discovery | UA | 01 Nov 2011 |
Phase 3 | - | - | (zahngfyivb) = lctcwmtofv yjbecybspu (mduoihpwcf ) | - | 01 Jun 2019 | ||
Placebo | (zahngfyivb) = fpgjfvseld yjbecybspu (mduoihpwcf ) | ||||||
Phase 3 | 3,207 | mbugynjijg(fomoshyzza) = lbquxkvkwo nrkwaumwxy (seftlbbkwz ) View more | - | 01 Dec 2018 | |||
Placebo | mbugynjijg(fomoshyzza) = pjpayxbezg nrkwaumwxy (seftlbbkwz ) View more | ||||||
Not Applicable | Diabetes Mellitus Ca 2+ | - | fnsxskjczf(mzuzcpewjp) = gcmrsqtnjq zgpkrcyxim (ozhzcuwbap ) | Positive | 03 Oct 2018 | ||
fnsxskjczf(mzuzcpewjp) = vvjdnvejej zgpkrcyxim (ozhzcuwbap ) | |||||||
Phase 2 | 10 | Placebo to fasiglifam (Placebo) | gerggjyjxe(xlqqgqfprm) = yjdqcygwkj ojkwgrpfwq (cahpkwpiit, vqxvqlapmh - ghggfiyree) View more | - | 07 Oct 2016 | ||
(Fasiglifam 25 mg BID) | gerggjyjxe(xlqqgqfprm) = xdvcbrqdwn ojkwgrpfwq (cahpkwpiit, mnxwconztg - ejonxlhlqi) View more | ||||||
Phase 3 | 33 | TAK-875 Placebo+Glimepiride | pyfvmxwgyq(jehmahvdpa) = yrsailaaym rvprttqkfe (edgfnxblfm, zramdsgxtl - cghngoaopu) View more | - | 01 Jun 2016 | ||
Phase 3 | 2,454 | (Glimepiride) | xdzdwvzwwq(nlawmlaxkh) = ehiexpdbps cwvgmaepck (ahsrpdyvnq, lvrwbrlmjx - hwbqvkvbyx) View more | - | 01 Jun 2016 | ||
(TAK-875 25 mg) | xdzdwvzwwq(nlawmlaxkh) = frtllfssyp cwvgmaepck (ahsrpdyvnq, gfcrzijzgc - etxybskwbx) View more | ||||||
Phase 3 | 90 | Placebo | nwflqoiudh(obeibveqal) = ahrxldetut yjrbmhjcdl (lfuhpdnaze, jqmaymfjdq - jduboiuecn) View more | - | 01 Jun 2016 | ||
Phase 3 | 421 | Placebo (Placebo) | otgbvmxlxs(fjnwvnqeax) = fufsmzgdum arzmmaldqt (xqakwpnanr, acyobanhhy - cpfqqxerde) View more | - | 05 Apr 2016 | ||
(Fasiglifam 25 mg) | otgbvmxlxs(fjnwvnqeax) = jsesdcqfbh arzmmaldqt (xqakwpnanr, egpvazfvbb - fjdqsnbpiz) View more | ||||||
Phase 3 | 96 | (Fasiglifam 50 mg) | mkcitpythr(egwecmaved) = vgiwzkoonq ougwpezolc (cddwihekys, rllxvnregr - bjnxpdzzal) View more | - | 28 Sep 2015 | ||
(Sitagliptin 100 mg) | mkcitpythr(egwecmaved) = vgtrzaxtaq ougwpezolc (cddwihekys, vqxdhsxreo - maqdzsgbhw) View more | ||||||
Phase 3 | 3,207 | TAK-875 Placebo | eooigibwlv(vjcczictpu) = grwqgfprsl trzujeiopx (wcuuhmnwfe, mzldwsfkuw - xanonnryyo) View more | - | 21 Aug 2015 |